SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Halozyme Therapeutics, Inc. Presents Positive Data from Two Ultrafast Insulin Clinical Trials with Human Hyaluronidase Enzyme - rHuPH20 - at American Diabetes Association2012